Corcept Therapeutics (CORT) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $121.05 +1.71%
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
EDXC, BICX, FBPI, More
Financial Fact:
Research and development: 7.05M
Today's EPS Names:
EDXC, BICX, FBPI, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.18, $0.03 better than the analyst estimate of $0.15. Revenue for the quarter came in at $66.8 million versus the consensus estimate of $69.61 million.
GUIDANCE:
Corcept Therapeutics sees FY2019 revenue of $285-315 million, versus the consensus of $298.3 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
